Sage Therapeutics to Host Conference Call

Rhea-AI Summary

Sage Therapeutics (Nasdaq: SAGE) announced a live webcast on June 15, 2021, at 8:00 a.m. ET to discuss topline results from the Phase 3 WATERFALL Study of zuranolone for major depressive disorder. This event can be accessed via the investor page on Sage's website. Following the live session, a replay will be available about two hours post-event. Sage Therapeutics focuses on novel therapies aimed at transforming the treatment of debilitating brain disorders, with a commitment to improving brain health.

Sage Therapeutics (Nasdaq: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced it will host a live webcast this morning, June 15, 2021 at 8:00 a.m. ET to review topline results from the Phase 3 WATERFALL Study evaluating zuranolone for major depressive disorder.

The webcast can be accessed on the investor page of Sage's website at investor.sagerx.com. A replay of the webcast will be available approximately two hours after the completion of the event.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health, and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner. For more information, please visit www.sagerx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210615005687/en/

FAQ

What is the purpose of the Sage Therapeutics webcast on June 15, 2021?

The webcast aims to review topline results from the Phase 3 WATERFALL Study evaluating zuranolone for major depressive disorder.

How can I access the Sage Therapeutics webcast?

You can access the webcast on the investor page of Sage Therapeutics' website.

What time does the Sage Therapeutics webcast start?

The webcast starts at 8:00 a.m. ET on June 15, 2021.

Will there be a replay available for the Sage Therapeutics webcast?

Yes, a replay of the webcast will be available approximately two hours after the event concludes.

What is Sage Therapeutics focusing on in its research?

Sage Therapeutics is focused on developing novel therapies for brain disorders, particularly in depression, neurology, and neuropsychiatry.